Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,595
→
🧬
Gene Target
15,505
→
🏥
Disease
30,170
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
🏥 Disease / Health Topic
Multiple Sclerosis
31
Clinical Trials
27
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT00841321
Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
Completed · Phase 2
NCT00276341
Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis
Completed · Phase 3
NCT02280876
Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)
Completed · Phase 1|Phase 2
📊 Sample Meta-Analyses
CRD42018105272
The incidence of adverse events of andrographis paniculata: a systematic review and meta-analysis
- Diagnoses of upper respiratory tract infections include common cold, laryngiti
CRD42020172575
Protocol for a systematic review without meta-analysis of the safety of sphingosine 1 phosphate modulators in inflammatory bowel disease and other immune-mediated diseases
Inflammatory bowel disease (Crohn's disease and ulcerative colitis), multiple sc
CRD42020199697
Protocol for systematic review and meta-analysis on Randomized clinical trials (placebo-controlled or comparator) on the efficacy and safety of sphingosine-1-phosphotase receptor modulators (amiselimod, ozanimod, ponesimod, siponimod)
Subjects with any type/stage or multiple sclerosis; adult; using sphingosine-1-p
📚 Sample References
None linked yet.
🏥 All Disease / Health Topic data fields for Multiple Sclerosis
🏥 Names
Disease Name
Multiple Sclerosis
Alias Names
Multiple Sclerosis, Acute Fulminating; Multiple Sclerosis
Topic Type
syndrome
🧬 Ontology Classifications
DisGeNET Type
disease
UMLS Type
Disease or Syndrome
MeSH Class
Immune System Diseases; Nervous System Diseases
DO Class
disease of anatomical entity
🔗 External References
🔍 Raw view — every non-empty column on this row (27 fields)
name
Multiple Sclerosis
alias name
Multiple Sclerosis, Acute Fulminating; Multiple Sclerosis
topic type
syndrome
disgenet disease type
disease
umls disease type
Disease or Syndrome
mesh disease class
Immune System Diseases; Nervous System Diseases
do disease class
disease of anatomical entity
umls disease type id
T047
mesh disease class id
C10; C20
do disease class id
DOID:7
herb disease id
HBDIS001992
disgenet id
C0026769
mesh id
D009103
do id
2377
icd10 id
G35
🌿 Related Herbs
5 · shared evidence⚗️ Related Ingredients
12 · shared evidence📋 Clinical Trials
12 · subject of clinical studyNCT00841321 Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis
→ Multiple Sclerosis|Cognitive Ability, General
NCT00276341 Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment
→ Multiple Sclerosis, Relapsing-Remitting
NCT02280876 Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in
→ Multiple Sclerosis, Relapsing-Remitting
NCT03944447 Outcomes Mandate National Integration With Cannabis as Medicine
→ Chronic Pain|Chronic Pain Syndrome|Chronic Pain Du
NCT02898974 Medical Marijuana and Its Effects on Motor Function in People With Multiple Scle
→ Multiple Sclerosis
NCT01037088 Effects of Vaporized Marijuana on Neuropathic Pain
→ Neuropathic Pain|Reflex Sympathetic Dystrophy|Peri
NCT00248378 Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Scler
→ Multiple Sclerosis
NCT00754832 American Ginseng Treatment for Multiple Sclerosis Related Fatigue
→ Multiple Sclerosis
NCT04120675 Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary
→ Progressive Multiple Sclerosis
NCT02506751 Open-label Study of Liothyronine in MS
→ Multiple Sclerosis, Relapsing-Remitting|Multiple S
NCT01514370 Dietary Supplement of Curcumin in Subjects With Active Relapsing Multiple Sclero
→ Multiple Sclerosis
NCT03740295 Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis
→ Multiple Sclerosis
📊 Meta-Analyses
12 · systematic reviewCRD42018105272 The incidence of adverse events of andrographis paniculata: a systematic review
→ - Diagnoses of upper respiratory tract infections
CRD42020172575 Protocol for a systematic review without meta-analysis of the safety of sphingos
→ Inflammatory bowel disease (Crohn's disease and ul
CRD42020199697 Protocol for systematic review and meta-analysis on Randomized clinical trials (
→ Subjects with any type/stage or multiple sclerosis
CRD42022367761 Intraocular Pressure Changes Following Glucosamine Use: A Meta-Analysis of Pre-P
→ The use of glucosamine has increased in recent dec
CRD42022363015 Myelin Oligodendrocyte Glycoprotein Antibody Disease Presenting Similar to Multi
→ Here, we will review cases of Myelin Oligodendrocy
CRD42016033054 The efficacy of inosine pranobex in non-HIV and non-cancer clinical conditions
→ Literature data concerning studies related to clin
CRD42016033054 The efficacy of inosine pranobex in non-HIV and non-cancer clinical conditions
→ Literature data concerning studies related to clin
CRD42017083037 Inosine for multiple sclerosis [Cochrane protocol]
→ The Cochrane Multiple Sclerosis and Rare Diseases
CRD42017083037 Inosine for multiple sclerosis [Cochrane protocol]
→ The Cochrane Multiple Sclerosis and Rare Diseases
CRD42016050246 Anti-inflammatory activity of melatonin in the treatment of multiple sclerosis:
→ Several studies have shown that melatonin reduces
CRD42022373972 Melatonin and melatonin receptor agonists for the treatment of sleep disturbance
→ The conditions under study are sleep-related behav
CRD42022360197 Efficacy and side effects of melatonin supplementation in patients with multiple
→ Multiple sclerosis: Multiple sclerosis (MS) is a c
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
empty — needs
HERB_herb_ingredientimport - Ingredient ↔ Target:
empty — needs
HERB_ingredient_targetimport - Target ↔ Disease:
empty — needs
HERB_target_diseaseimport - Herb → Target → Disease (full chemical spine): awaiting Phase 2e link tables